Sandra Okala

Sandra Okala is a researcher with a focus on maternal health, infectious diseases, and global public health. Her work spans a range of disciplines including pregnancy outcomes, HIV/AIDS research, and vaccine efficacy. She has contributed to studies in rural Gambia and low- and middle-income countries (LMICs), examining topics such as lipid levels during pregnancy and their impact on birth outcomes, as well as the effects of maternal nutrition on infant immunity. Okala’s research also addresses urgent challenges like antibiotic-resistant infections and antiviral therapies for transplant recipients. Her studies often employ cohort analyses and observational methodologies, emphasizing real-world applicability in resource-limited settings.

Her research interests include maternal and child health, epidemiology of infectious diseases, vaccine development, and clinical trial design. Notable projects include evaluating the efficacy of maribavir in cytomegalovirus (CMV) infections among transplant recipients and investigating the prevalence of STI coinfections in urban clinics. Okala’s work frequently intersects with public health policy, such as improving pregnancy registry enrollment accuracy and optimizing healthcare resource allocation for osteoarthritis patients with inadequate pain management.

Though no formal academic rank or institution is explicitly stated in the text, her publications suggest active involvement in multidisciplinary research teams, often collaborating with institutions in The Gambia, the UK, and other international partners. Her studies are characterized by methodological rigor and a focus on translational outcomes to address global health inequities.